A Trial of Telemonitoring in Adults With Heart Failure

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01393314
Recruitment Status : Completed
First Posted : July 13, 2011
Last Update Posted : July 13, 2011
Information provided by:
University Hospitals Cleveland Medical Center

Brief Summary:

This is a randomized controlled trial of telemonitoring vs usual care provided by home care agencies for atients with HF.

The study hypothesis is that Telemonitoring will reduce hospital re-admission rates, urgent care visits, unscheduled physician appointments, ER visits in patients with heart failure over the 60 day post hospitalization period.

Condition or disease Intervention/treatment Phase
Heart Failure Device: Honeywell HomMed Telemonitor Not Applicable

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 105 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: A Randomized Controlled Trial of Telemonitoring in Older Adults With Heart Failure
Study Start Date : November 2007
Actual Primary Completion Date : March 2010
Actual Study Completion Date : March 2010

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Heart Failure

Arm Intervention/treatment
Active Comparator: Honeywell HomMed Telemonitor Device: Honeywell HomMed Telemonitor
telemonitoring post hospitalization

No Intervention: usual care

Primary Outcome Measures :
  1. rehospitalization [ Time Frame: Particpants were followed for the duration of home care services up to 12 months ]

Secondary Outcome Measures :
  1. health status [ Time Frame: Particpants were followed for the duration of home care services up to 12 months ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   55 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • HF (primary or secondary) diagnosis regardless of ejection fraction (EF) and NYHA class II- IV at the time of HHC admission and HHC services initiated following a hospital stay

Exclusion Criteria:

  • inability to stand on a scale, weight over 500 lbs, unable to hear and/or see, or no working land line phone in the residence.
  • Additional exclusion criteria were: patients with severe ischemic heart disease, MI and/or CABG in the last 6 weeks, severe uncorrected valvular disease, home inotropic therapy, severe lung disease (oxygen dependent), active cancer, uncorrected thyroid disease, AIDS, or end stage renal disease on dialysis.

Responsible Party: Rebecca Boxer, MD, Case Western Reserve University Identifier: NCT01393314     History of Changes
Other Study ID Numbers: 1KL2RR024990 - 2
1KL2RR024990 ( U.S. NIH Grant/Contract )
First Posted: July 13, 2011    Key Record Dates
Last Update Posted: July 13, 2011
Last Verified: June 2011

Additional relevant MeSH terms:
Heart Failure
Heart Diseases
Cardiovascular Diseases